Cargando…

Effects of ivabradine and atenolol on heart rate and heart rate variability in healthy cats over a 24 h period: A pilot study

BACKGROUND: Ivabradine is used to treat tachycardia; unlike atenolol, it does not affect blood pressure or myocardial contractility. This study compared the impact of ivabradine and atenolol on heart rate (HR) and HR variability (HRV) during a 24 h period, feeding and sleeping times, via a Holter el...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogawa, Mizuki, Kawamura, Ayano, Akabane, Ryota, Sakatani, Atsushi, Miyakawa, Hirosumi, Hsu, Huai‐Hsun, Miyagawa, Yuichi, Takemura, Naoyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827492/ https://www.ncbi.nlm.nih.gov/pubmed/35154785 http://dx.doi.org/10.1002/vro2.28

Ejemplares similares

Relationship between right heart echocardiographic parameters and invasive pulmonary artery pressures in canine models of chronic embolic pulmonary hypertension
por: AKABANE, Ryota, et al.
Publicado: (2019)

Serum cystatin C concentration can be used to evaluate glomerular filtration rate in small dogs
por: MIYAGAWA, Yuichi, et al.
Publicado: (2020)

Association between serum fibroblast growth factor‐23 concentration and development of hyperphosphatemia in normophosphatemic dogs with chronic kidney disease
por: Miyakawa, Hirosumi, et al.
Publicado: (2021)

A pilot study of patch Holter electrocardiograph recordings in healthy cats
por: Ogawa, Mizuki, et al.
Publicado: (2022)

Pharmacokinetics of single dose sildenafil orally administered in canine models of chronic embolic pulmonary hypertension
por: AKABANE, Ryota, et al.
Publicado: (2020)

Assessment of the measurement of canine and feline serum fibroblast growth factor-23 concentrations by automated chemiluminescence immunoassay
por: MIYAKAWA, Hirosumi, et al.
Publicado: (2021)

A dog presenting with syncope due to two different etiologies
por: Ogawa, Mizuki, et al.
Publicado: (2022)

Comparison of N-terminal pro-atrial natriuretic peptide and three cardiac biomarkers for discriminatory ability of clinical stage in dogs with myxomatous mitral valve disease
por: OGAWA, Mizuki, et al.
Publicado: (2021)

Evaluation of the association between electrocardiogram parameters and left cardiac remodeling in dogs with myxomatous mitral valve disease
por: Ogawa, Mizuki, et al.
Publicado: (2022)

Plasma N-terminal pro-atrial natriuretic peptide concentrations are affected by dehydration in healthy dogs
por: Ogawa, Mizuki, et al.
Publicado: (2023)

Heart Rate Reduction by Ivabradine: Slowly but Surely?
por: Kojonazarov, Baktybek
Publicado: (2020)

Ivabradine in Cardiovascular Disease: Heart Rate Isn't Everything
por: Feldman, Arthur M.
Publicado: (2015)

Heart rate manipulation in dilated cardiomyopathy: Assessing the role of Ivabradine
por: Raja, Deep Chandh, et al.
Publicado: (2018)

Ivabradine Improves Heart Rate Variability in Patients with Nonischemic Dilated Cardiomyopathy
por: Kurtoglu, Ertugrul, et al.
Publicado: (2014)

The effect of the heart rate lowering drug Ivabradine on hemodynamics in atherosclerotic mice
por: Xing, R., et al.
Publicado: (2018)

Implications of Doppler Echocardiography-guided Heart Rate Modulation Using Ivabradine
por: Hori, Masakazu, et al.
Publicado: (2021)

Ivabradine, the pure heart rate-lowering drug, shown to reduce morbidity and mortality in heart failure
Publicado: (2010)

A comparative study of nebivolol and (S) atenolol on blood pressure and heart rate on essential hypertensive patients
por: Sahana, G.N., et al.
Publicado: (2010)

The Effect of Ivabradine on the Heart Rate and Sympathovagal Balance in Postural Tachycardia Syndrome Patients
por: Barzilai, Merav, et al.
Publicado: (2015)

Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2020)

Atenolol's Inferior Ability to Reduce Central vs Peripheral Blood Pressure Can Be Explained by the Combination of Its Heart Rate-Dependent and Heart Rate-Independent Effects
por: Teeäär, Tuuli, et al.
Publicado: (2020)

Baseline intrinsic heart rate and response to ivabradine treatment in patients with inappropriate sinus tachycardia
por: Kaczmarek, Krzysztof, et al.
Publicado: (2019)

Ivabradine Ameliorates Cardiac Diastolic Dysfunction in Diabetic Mice Independent of Heart Rate Reduction
por: Xie, Hao, et al.
Publicado: (2021)

Ivabradine tolerability in heart failure
por: Birkhoelzer, Sarah, et al.
Publicado: (2018)

Correction to: Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2021)

Doppler Echocardiography-Guided Heart Rate Modulation Therapy Using Ivabradine in a Patient with Systolic Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2022)

A case report of ivabradine used for heart rate control of atrial fibrillation in acute decompensated heart failure
por: Hardison, Edward, et al.
Publicado: (2022)

Adding ivabradine to beta-blockers in chronic heart failure: Do not rest without lowering the resting heart rate sufficiently
por: Oomman, Abraham, et al.
Publicado: (2018)

Report of a patient with refractory atrial tachycardia whose heart rate was controlled using ivabradine
por: Zhao, Lanting, et al.
Publicado: (2022)

Ivabradine Prevents Heart Rate Acceleration in Patients with Chronic Obstructive Pulmonary Disease and Coronary Heart Disease after Salbutamol Inhalation
por: Zulkarneev, Rustem, et al.
Publicado: (2012)

Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.
por: Bouabdallaoui, Nadia, et al.
Publicado: (2019)

Concomitant administration of simvastatin with ivabradine in contrast to metoprolol intensifies slowing of heart rate in normo- and hypercholesterolemic rats
por: Owczarek, Jacek, et al.
Publicado: (2012)

Acute effect of ivabradine on heart rate and myocardial oxygen consumption in dogs with asymptomatic mitral valve degeneration
por: Pirintr, Prapawadee, et al.
Publicado: (2018)

Effect of ivabradine on heart rate, functional capacity and pulmonary artery pressure in patients of COPD with cor pulmonale
por: Kaleem, Mohammad, et al.
Publicado: (2021)

Advances in the management of heart failure: the role of ivabradine
por: Müller-Werdan, Ursula, et al.
Publicado: (2016)

Concomitant Administration of Different Doses of Simvastatin with Ivabradine Influence on PAI-1 and Heart Rate in Normo- and Hypercholesterolaemic Rats
por: Owczarek, Jacek, et al.
Publicado: (2012)

Effects of selective heart rate reduction with ivabradine on LV function and central hemodynamics in patients with chronic coronary syndrome
por: Hohneck, Anna Lena, et al.
Publicado: (2021)

Effect of ivabradine-induced heart rate reduction on flow-mediated dilation measured with high-sensitivity ultrasound in patients with stable coronary heart disease
por: Jochmann, Nicoline, et al.
Publicado: (2014)

Comparison of the effects of long-term pimobendan and benazepril administration in normal cats
por: MIYAGAWA, Yuichi, et al.
Publicado: (2016)

Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy
por: Tardif, Jean-Claude, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nsp58b8un78cofq08tnscbf8mt